Bicara Therapeutics Inc.

BCAXReported to SECin USCIK 0002023658Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 32. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 32
Form 4 lines at Bicara Therapeutics Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Cohlhepp RyanPresident, COO & Interim CEOOption exercisenothing paid17,500 sharesSep 10, 2026Cohlhepp RyanPresident, COO & Interim CEOnothing paidExercise · Sep 10Option exercise17,500Sep 10, 2026
Cohlhepp RyanPresident, COO & Interim CEOOpen-market sell$80,6633,442 sharesSep 10, 2026Cohlhepp RyanPresident, COO & Interim CEO$80,663Sell · Sep 10Open-market sell3,442Sep 10, 2026
Cohlhepp RyanPresident, COO & Interim CEOOpen-market sell$320,05314,058 sharesSep 10, 2026Cohlhepp RyanPresident, COO & Interim CEO$320,053Sell · Sep 10Open-market sell14,058Sep 10, 2026
Cohlhepp RyanPresident, COO & Interim CEOOption exercise$66,32217,500 sharesSep 10, 2026Cohlhepp RyanPresident, COO & Interim CEO$66,322Exercise · Sep 10Option exercise17,500Sep 10, 2026
Larson JenniferChief Financial OfficerAwardnothing paid285,000 sharesAug 14, 2026Larson JenniferChief Financial Officernothing paidAward · Aug 14Award285,000Aug 14, 2026